COVID vaccine from Germany's CureVac just 48% effective
Germany's CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech/Pfizer and Moderna.
Jul 1, 2021
0
2